1
|
Liu N, Li M, Xie F, Lv J, Gao X, Zhang H, Gao J, Zheng A. Efficacy of mimetic viral dynein binding peptide binding nanoparticles in blood-brain barrier model. J Drug Deliv Sci Technol 2022. [DOI: 10.1016/j.jddst.2022.103523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
2
|
Dalmau-Mena I, Del Pino P, Pelaz B, Cuesta-Geijo MÁ, Galindo I, Moros M, de la Fuente JM, Alonso C. Nanoparticles engineered to bind cellular motors for efficient delivery. J Nanobiotechnology 2018; 16:33. [PMID: 29602307 PMCID: PMC5877387 DOI: 10.1186/s12951-018-0354-1] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2017] [Accepted: 03/19/2018] [Indexed: 11/17/2022] Open
Abstract
Background Dynein is a cytoskeletal molecular motor protein that transports cellular cargoes along microtubules. Biomimetic synthetic peptides designed to bind dynein have been shown to acquire dynamic properties such as cell accumulation and active intra- and inter-cellular motion through cell-to-cell contacts and projections to distant cells. On the basis of these properties dynein-binding peptides could be used to functionalize nanoparticles for drug delivery applications. Results Here, we show that gold nanoparticles modified with dynein-binding delivery sequences become mobile, powered by molecular motor proteins. Modified nanoparticles showed dynamic properties, such as travelling the cytosol, crossing intracellular barriers and shuttling the nuclear membrane. Furthermore, nanoparticles were transported from one cell to another through cell-to-cell contacts and quickly spread to distant cells through cell projections. Conclusions The capacity of these motor-bound nanoparticles to spread to many cells and increasing cellular retention, thus avoiding losses and allowing lower dosage, could make them candidate carriers for drug delivery. Electronic supplementary material The online version of this article (10.1186/s12951-018-0354-1) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Inmaculada Dalmau-Mena
- Dpt. Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Carretera de la Coruña km 7.5, 28040, Madrid, Spain
| | - Pablo Del Pino
- Instituto de Nanociencia de Aragón, Universidad de Zaragoza, Mariano Esquillor, s/n, 50018, Zaragoza, Spain.,Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Física de Partículas, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain
| | - Beatriz Pelaz
- Instituto de Nanociencia de Aragón, Universidad de Zaragoza, Mariano Esquillor, s/n, 50018, Zaragoza, Spain.,Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Física de Partículas, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain
| | - Miguel Ángel Cuesta-Geijo
- Dpt. Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Carretera de la Coruña km 7.5, 28040, Madrid, Spain
| | - Inmaculada Galindo
- Dpt. Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Carretera de la Coruña km 7.5, 28040, Madrid, Spain
| | - María Moros
- Instituto de Nanociencia de Aragón, Universidad de Zaragoza, Mariano Esquillor, s/n, 50018, Zaragoza, Spain
| | - Jesús M de la Fuente
- Aragon Materials Science Institute (ICMA), CSIC-University of Zaragoza and CIBER-BBN, C/Pedro Cerbuna 12, 50009, Zaragoza, Spain
| | - Covadonga Alonso
- Dpt. Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Carretera de la Coruña km 7.5, 28040, Madrid, Spain.
| |
Collapse
|
3
|
Intracellular trafficking of a dynein-based nanoparticle designed for gene delivery. Eur J Pharm Sci 2018; 112:71-78. [DOI: 10.1016/j.ejps.2017.11.002] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2017] [Revised: 10/09/2017] [Accepted: 11/01/2017] [Indexed: 12/29/2022]
|